Browsing byAuthorWebster R

Jump to a point in the index:
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)
2019-09Barriers and Facilitators to the Use of Cardiovascular Fixed-Dose Combination Medication (Polypills) in Andhra Pradesh, India: A Mixed-Methods Study.Salam A; Praveen D; Patel A; Tewari A; Webster R
2019-07-16Process evaluation in the field: global learnings from seven implementation research hypertension projects in low-and middle-income countries.Limbani F; Goudge J; Joshi R; Maar MA; Miranda JJ; Oldenburg B; Parker G; Pesantes MA; Riddell MA; Salam A; Trieu K; Thrift AG; Van Olmen J; Vedanthan R; Webster R; Yeates K; Webster J; Global Alliance for Chronic Diseases, Process Evaluation Working Group
2019-05Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials.Salam A; Atkins ER; Hsu B; Webster R; Patel A; Rodgers A
2019-02Fixed-dose combination medications for non-communicable diseases.Webster R
2019-01The role of context in implementation research for non-communicable diseases: Answering the 'how-to' dilemma.Daivadanam M; Ingram M; Sidney Annerstedt K; Parker G; Bobrow K; Dolovich L; Gould G; Riddell M; Vedanthan R; Webster J; Absetz P; Mölsted Alvesson H; Androutsos O; Chavannes N; Cortez B; Devarasetty P; Fottrell E; Gonzalez-Salazar F; Goudge J; Herasme O; Jennings H; Kapoor D; Kamano J; Kasteleyn MJ; Kyriakos C; Manios Y; Mogulluru K; Owolabi M; Lazo-Porras M; Silva W; Thrift A; Uvere E; Webster R; van der Kleij R; van Olmen J; Vardavas C; Zhang P; GACD Concepts and Contexts working group
2016-03-29Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints.Patel A; Webster R
2016-01The potential and value of epidemiology in curbing non-communicable diseases.Patel A; Webster R
2015-11-09Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme.GACD Hypertension Research Programme, Writing Group; Peiris D; Thompson SR; Beratarrechea A; Cárdenas MK; Diez-Canseco F; Goudge J; Gyamfi J; Kamano JH; Irazola V; Johnson C; Kengne AP; Keat NK; Miranda JJ; Mohan S; Mukasa B; Ng E; Nieuwlaat R; Ogedegbe O; Ovbiagele B; Plange-Rhule J; Praveen D; Salam A; Thorogood M; Thrift AG; Vedanthan R; Waddy SP; Webster J; Webster R; Yeates K; Yusoff K; Hypertension Research Programme members
2012-01The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.Elley CR; Gupta AK; Webster R; Selak V; Jun M; Patel A; Rodgers A; Thom S
2011-01An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.PILL Collaborative Group; Rodgers A; Patel A; Berwanger O; Bots M; Grimm R; Grobbee DE; Jackson R; Neal B; Neaton J; Poulter N; Rafter N; Raju PK; Reddy S; Thom S; Vander Hoorn S; Webster R
2010-01Perceptions of risk: understanding cardiovascular disease.Webster R; Heeley E